Documenting the selection of quadrupedal walking gaits in a spread of marsupials (arboreal vs. terrestrial, with and with out greedy hind toes), to help in creating and refining a normal concept of gait evolution in primates.Video information of koalas, ringtail possums, tree kangaroos, sugar gliders, squirrel gliders, wombats, numbats, quolls, a thylacine, and an opossum walking on a spread of substrates had been made and analyzed to derive obligation elements and diagonalities for symmetrical walking gaits.
The ensuing distributions of knowledge factors had been in contrast with revealed knowledge and theories.Terrestrial marsupials’ gaits overwhelmingly plot barely beneath the theoretical “horse line” (Cartmill et al., Zoological Journal of the Linnean Society. 2002;136:401-420) typical of terrestrial mammals; arboreal marsupials’ gaits overwhelmingly plot extra decisively above it.
Both distributions are roughly parallel to the horse line, however arboreal animals exhibit elevated diagonality, in order that their higher-speed walking gaits overlap with these of typical primates on the Hildebrand diagram of diagonality in opposition to obligation issue.Quadrupeds keep away from gaits mendacity precisely on the (theoretically optimum) horse line, to keep away from fore/hind limb interference (“forging”).
This may be achieved by both a slight discount in diagonality (“downshifting”) or a extra decisive enhance (“upshifting”). Tree-dwellers undertake the second choice to get rid of unilateral bipods of assist from the gait cycle. The upshifted horse line represents an early part in the evolution of primate-like diagonal-sequence gaits.
Microbiological survey of sugar gliders (Petaurus breviceps) saved as pets in Italy.
The sugar glider (Petaurus breviceps) is a small, arboreal, nocturnal, gliding mammalian possum belonging to the marsupial infraclass. Exotic marsupials, together with sugar gliders, have gotten common companion pets and, consequently, the danger of potential infections that may be transmitted to people must be investigated.
Data on the position of the sugar glider as a potential provider of pathogenic and zoonotic micro organism are scarce and fragmentary. Therefore, this examine is aimed toward evaluating the prevalence of doubtlessly zoonotic micro organism (Salmonella spp., Escherichia coli, Campylobacter spp., Pseudomonas spp., Klebsiella spp., Listeria monocytogenes and Yersinia enterocolitica) in 64 sugar gliders saved as pets in Italy.
The highest prevalence of an infection pertained to members of the household Enterobacteriaceae, in specific Citrobacter spp. (50%), Enterobacter spp. (28.1%) and Klebsiella pneumoniae (15.6%); Pseudomonas aeruginosa was remoted from 10 out of 64 samples (15.6%). All strains of Klebsiella pneumoniae exhibited some stage of resistance to a number of antimicrobials (ampicillin, amoxicillin-clavulanic acid and doxycycline).
Diseases of the urinary tract are reviewed, protecting infectious (bacterial, viral, parasitic), degenerative, congenital, metabolic, dietary, neoplastic, obstructive, and poisonous causes. Some medical shows and diagnostic procedures are described for ferrets, rabbits, guinea pigs, hamsters, mice, rats, chinchillas, hedgehogs, and sugar gliders, in addition to therapies.
Morphology of the Lingual Papillae of the Japanese lesser flying squirrel and four-toed hedgehog.
Author examined the dorsal lingual surfaces of the grownup Japanese lesser flying squirrel (Pteromys momonga) and four-toed hedgehog (Atelerix albiventris) by scanning electron microscopy. In the Japanese lesser flying squirrel, the filiform papilla of the lingual physique consisted of a big conical papilla. The filiform papilla of the lingual prominence was spoon in form.
The fungiform papillae had been spherical in form and scattered amongst the filiform papillae. Many foliate papillae had been noticed on the posterolateral areas of the lingual physique. The foliate papillae had some ridges separated by deep grooves. The vallate papilla was positioned between lingual physique and root. Several lengthy conical papillae derived from the posterolateral margin of the tongue. In the four-toed hedgehog, the filiform papilla of the lingual apex had a conical course of.
The filiform papilla of the lingual physique had some processes. The fungiform papillae had been spherical in form. The foliate papillae had been noticed on the posterolateral areas of the lingual physique. The papilla was separated from one another by a furrow. The vallate papilla consisted of a central papilla and an annular pad.
These findings recommend that in the construction of the lingual papillae of the Japanese lesser flying squirrel there may be much like that of the sugar glider and the lingual papillae of the four-toed hedgehog is totally different from that of the Japanese lesser flying squirrel.
Swift declines predicted following mating system modifications pushed by an launched predator.
In Focus: Heinsohn, R., Olah, G., Webb, M., Peakall, R., & Stojanovic, D. (2019). Sex ratio bias and shared paternity scale back particular person health and inhabitants viability in a critically endangered parrot. Journal of Animal Ecology, 88, 502-510. While the results of variation in the intercourse ratio of offspring have been completely explored over the final century, the intercourse ratio of adults has obtained far much less consideration.
A paper by Heinsohn and colleagues in this problem exhibits that modifications in the grownup intercourse ratio can have hanging results on mating techniques, reproductive success and inhabitants viability. These impacts are all the extra dramatic as a result of they happen in a critically endangered species, the swift parrot, Lathamus discolor, of Tasmania.
This species suffers heavy predation from the launched sugar glider, Petaurus breviceps, which kills nesting females and their clutches, ensuing in strongly male-biased grownup intercourse ratios.
Human SLC50A1 ELISA Kit |
|||
ELA-E15030h | Lifescience Market | 96 Tests | 988.8 EUR |
SLC50A1 ELISA KIT|Human |
|||
EF005869 | Lifescience Market | 96 Tests | 826.8 EUR |
SLC50A1 Recombinant Protein (Human) |
|||
RP097482 | ABM | 100 ug | Ask for price |
SLC50A1 Recombinant Protein (Rat) |
|||
RP229691 | ABM | 100 ug | Ask for price |
SLC50A1 Recombinant Protein (Mouse) |
|||
RP173330 | ABM | 100 ug | Ask for price |
Polyclonal SLC50A1 antibody - C-terminal region |
|||
APR01528G | Leading Biology | 0.05mg | 633.6 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SLC50A1 - C-terminal region. This antibody is tested and proven to work in the following applications: |
|||
SLC50A1 ELISA Kit (Human) (OKEH02450) |
|||
OKEH02450 | Aviva Systems Biology | 96 Wells | 934.8 EUR |
Description: Description of target: ;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.098 ng/mL |
|||
SLC50A1 ELISA Kit (Rat) (OKEH04196) |
|||
OKEH04196 | Aviva Systems Biology | 96 Wells | 794.4 EUR |
Description: Description of target: Mediates sugar transport across membranes. May stimulate V(D)J recombination by the activation of RAG1 (By similarity).;Species reactivity: Rat;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.094 ng/mL |
|||
SLC50A1 ELISA Kit (Mouse) (OKEH04197) |
|||
OKEH04197 | Aviva Systems Biology | 96 Wells | 794.4 EUR |
Description: Description of target: Mediates sugar transport across membranes (By similarity). May regulate the expression of RAG1 a gene involved in V(D)J recombination;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 39.4 pg/mL |
|||
Slc50a1 ORF Vector (Rat) (pORF) |
|||
ORF076565 | ABM | 1.0 ug DNA | 607.2 EUR |
Slc50a1 ORF Vector (Mouse) (pORF) |
|||
ORF057778 | ABM | 1.0 ug DNA | 607.2 EUR |
SLC50A1 ORF Vector (Human) (pORF) |
|||
ORF032495 | ABM | 1.0 ug DNA | Ask for price |
Slc50a1 sgRNA CRISPR Lentivector set (Rat) |
|||
K7600101 | ABM | 3 x 1.0 ug | 406.8 EUR |
SLC50A1 sgRNA CRISPR Lentivector set (Human) |
|||
K2804901 | ABM | 3 x 1.0 ug | 406.8 EUR |
Slc50a1 sgRNA CRISPR Lentivector set (Mouse) |
|||
K3828901 | ABM | 3 x 1.0 ug | 406.8 EUR |
Rat Slc50a1/ Sugar transporter SWEET1 ELISA Kit |
|||
E0914Ra | Sunlong | 1 Kit | Ask for price |
Mouse Slc50a1/ Sugar transporter SWEET1 ELISA Kit |
|||
E1373Mo | Sunlong | 1 Kit | 758.4 EUR |
Mouse Sugar transporter SWEET1 (SLC50A1) ELISA Kit |
|||
abx517455-96tests | Abbexa | 96 tests | 801.6 EUR |
Rat Sugar transporter SWEET1 (SLC50A1) ELISA Kit |
|||
abx517456-96tests | Abbexa | 96 tests | 801.6 EUR |
Human Sugar transporter SWEET1 (SLC50A1) ELISA Kit |
|||
abx251029-96tests | Abbexa | 96 tests | 886.8 EUR |
Slc50a1 sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
K7600102 | ABM | 1.0 ug DNA | 184.8 EUR |
Slc50a1 sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
K7600103 | ABM | 1.0 ug DNA | 184.8 EUR |
Slc50a1 sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
K7600104 | ABM | 1.0 ug DNA | 184.8 EUR |
Human SLC50A1(Sugar transporter SWEET1) ELISA Kit |
|||
EH1727 | FN Test | 96T | 681.12 EUR |
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.094 ng/ml |
|||
Mouse Sugar transporter SWEET1, Slc50a1 ELISA KIT |
|||
ELI-41057m | Lifescience Market | 96 Tests | 1038 EUR |
Human Sugar transporter SWEET1, SLC50A1 ELISA KIT |
|||
ELI-29917h | Lifescience Market | 96 Tests | 988.8 EUR |
Human SLC50A1/ Sugar transporter SWEET1 ELISA Kit |
|||
E2331Hu | Sunlong | 1 Kit | 726 EUR |
SLC50A1 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
K2804902 | ABM | 1.0 ug DNA | 184.8 EUR |
SLC50A1 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
K2804903 | ABM | 1.0 ug DNA | 184.8 EUR |
SLC50A1 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
K2804904 | ABM | 1.0 ug DNA | 184.8 EUR |
Slc50a1 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
K3828902 | ABM | 1.0 ug DNA | 184.8 EUR |
Slc50a1 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
K3828903 | ABM | 1.0 ug DNA | 184.8 EUR |
Slc50a1 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
K3828904 | ABM | 1.0 ug DNA | 184.8 EUR |
SLC50A1 Protein Vector (Human) (pPB-C-His) |
|||
PV129978 | ABM | 500 ng | Ask for price |
SLC50A1 Protein Vector (Human) (pPB-N-His) |
|||
PV129979 | ABM | 500 ng | Ask for price |
SLC50A1 Protein Vector (Human) (pPM-C-HA) |
|||
PV129980 | ABM | 500 ng | Ask for price |
SLC50A1 Protein Vector (Human) (pPM-C-His) |
|||
PV129981 | ABM | 500 ng | Ask for price |
SLC50A1 Protein Vector (Rat) (pPB-C-His) |
|||
PV306258 | ABM | 500 ng | 723.6 EUR |
SLC50A1 Protein Vector (Rat) (pPB-N-His) |
|||
PV306259 | ABM | 500 ng | 723.6 EUR |
SLC50A1 Protein Vector (Rat) (pPM-C-HA) |
|||
PV306260 | ABM | 500 ng | 723.6 EUR |
SLC50A1 Protein Vector (Rat) (pPM-C-His) |
|||
PV306261 | ABM | 500 ng | 723.6 EUR |
SLC50A1 Protein Vector (Mouse) (pPB-C-His) |
|||
PV231110 | ABM | 500 ng | 723.6 EUR |
SLC50A1 Protein Vector (Mouse) (pPB-N-His) |
|||
PV231111 | ABM | 500 ng | 723.6 EUR |
SLC50A1 Protein Vector (Mouse) (pPM-C-HA) |
|||
PV231112 | ABM | 500 ng | 723.6 EUR |
SLC50A1 Protein Vector (Mouse) (pPM-C-His) |
|||
PV231113 | ABM | 500 ng | 723.6 EUR |
Slc50a1 3'UTR Luciferase Stable Cell Line |
|||
TU220696 | ABM | 1.0 ml | Ask for price |
Slc50a1 3'UTR GFP Stable Cell Line |
|||
TU169174 | ABM | 1.0 ml | Ask for price |
Slc50a1 3'UTR GFP Stable Cell Line |
|||
TU270696 | ABM | 1.0 ml | Ask for price |
Slc50a1 3'UTR Luciferase Stable Cell Line |
|||
TU119174 | ABM | 1.0 ml | Ask for price |
SLC50A1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
|||
LV687895 | ABM | 1.0 ug DNA | 616.8 EUR |
SLC50A1 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
LV687899 | ABM | 1.0 ug DNA | 616.8 EUR |
SLC50A1 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
LV687900 | ABM | 1.0 ug DNA | 616.8 EUR |
Slc50a1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
|||
K7600105 | ABM | 3 x 1.0 ug | 451.2 EUR |
SLC50A1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
K2804905 | ABM | 3 x 1.0 ug | 451.2 EUR |
Slc50a1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
K3828905 | ABM | 3 x 1.0 ug | 451.2 EUR |
Slc50a1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
|||
K7600106 | ABM | 1.0 ug DNA | 200.4 EUR |
Slc50a1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
|||
K7600107 | ABM | 1.0 ug DNA | 200.4 EUR |
Slc50a1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
|||
K7600108 | ABM | 1.0 ug DNA | 200.4 EUR |
SLC50A1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA) |
|||
LV687896 | ABM | 1.0 ug DNA | 616.8 EUR |
SLC50A1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
|||
LV687897 | ABM | 1.0 ug DNA | 686.4 EUR |
SLC50A1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
|||
LV687898 | ABM | 1.0 ug DNA | 686.4 EUR |
SLC50A1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
K2804906 | ABM | 1.0 ug DNA | 200.4 EUR |
SLC50A1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
K2804907 | ABM | 1.0 ug DNA | 200.4 EUR |
SLC50A1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
K2804908 | ABM | 1.0 ug DNA | 200.4 EUR |
Slc50a1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
K3828906 | ABM | 1.0 ug DNA | 200.4 EUR |
Slc50a1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|||
K3828907 | ABM | 1.0 ug DNA | 200.4 EUR |
Slc50a1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|||
K3828908 | ABM | 1.0 ug DNA | 200.4 EUR |
ASAP1 antibody Antibody |
|||
DF8746 | Affbiotech | 200ul | 420 EUR |
CD11b Antibody Antibody |
|||
ABD2911 | Lifescience Market | 100 ug | 525.6 EUR |
anti- Antibody^Polyclonal antibody control antibody |
|||
LSMab09882 | Lifescience Market | 100 ug | 525.6 EUR |
ARHGDIA Antibody / RHOGDI Antibody |
|||
F54788-0.08ML | NSJ Bioreagents | 0.08 ml | 165 EUR |
ARHGDIA Antibody / RHOGDI Antibody |
|||
F54788-0.4ML | NSJ Bioreagents | 0.4 ml | 379 EUR |
Antibody |
|||
A1360-500 | Biovision | Ask for price | |
Ly1 Antibody Reactive (LYAR) Antibody |
|||
20-abx123734 | Abbexa |
|
|
Anti-Glycolipid Antibody (AGA) Antibody |
|||
20-abx004855 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
|||
20-abx014333 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
|||
20-abx008109 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
|||
abx033330-400ul | Abbexa | 400 ul | 627.6 EUR |
Ly1 Antibody Reactive (LYAR) Antibody |
|||
abx033330-80l | Abbexa | 80 µl | 343.2 EUR |
Anti-Glycolipid Antibody (AGA) Antibody |
|||
abx036399-100ug | Abbexa | 100 ug | 469.2 EUR |
Anti-Glycolipid Antibody (AGA) Antibody |
|||
abx230204-100ug | Abbexa | 100 ug | 577.2 EUR |
Anti-Glycoprotein Antibody (GP) Antibody |
|||
20-abx319900 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody |
|||
20-abx319901 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody |
|||
20-abx319905 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody |
|||
20-abx319913 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
|||
20-abx311665 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
|||
20-abx324434 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
|||
abx234901-100ug | Abbexa | 100 ug | 661.2 EUR |
Anti-Anti-SEPT6 antibody antibody |
|||
STJ11100949 | St John's Laboratory | 100 µl | 332.4 EUR |
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined. |
|||
Anti-Anti-SEPT9 Antibody antibody |
|||
STJ111369 | St John's Laboratory | 100 µl | 332.4 EUR |
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described. |
|||
Anti-Anti-SEPT11 Antibody antibody |
|||
STJ111530 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT4 Antibody antibody |
|||
STJ112276 | St John's Laboratory | 100 µl | 332.4 EUR |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. One of the isoforms (known as ARTS) is distinct; it is localized to the mitochondria, and has a role in apoptosis and cancer. |
|||
Anti-Anti-MARCH9 Antibody antibody |
|||
STJ112609 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT2 Antibody antibody |
|||
STJ25475 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT5 Antibody antibody |
|||
STJ25477 | St John's Laboratory | 100 µl | 332.4 EUR |
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
|||
Anti-Anti-SEPT8 Antibody antibody |
|||
STJ25479 | St John's Laboratory | 100 µl | 332.4 EUR |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
|||
Anti-Anti-SEPT2 Antibody antibody |
|||
STJ28365 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT7 Antibody antibody |
|||
STJ28963 | St John's Laboratory | 100 µl | 332.4 EUR |
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
|||
Anti-Anti-SEPT1 antibody antibody |
|||
STJ119580 | St John's Laboratory | 100 µl | 332.4 EUR |
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis and the maintenance of cellular morphology. This gene encodes a protein that can form homo- and heterooligomeric filaments, and may contribute to the formation of neurofibrillary tangles in Alzheimer's disease. Alternatively spliced transcript variants have been found but the full-length nature of these variants has not been determined. [provided by RefSeq, Dec 2012] |
|||
Anti-Anti-SEPT12 Antibody antibody |
|||
STJ117759 | St John's Laboratory | 100 µl | 332.4 EUR |
Description: This gene encodes a guanine-nucleotide binding protein and member of the septin family of cytoskeletal GTPases. Septins play important roles in cytokinesis, exocytosis, embryonic development, and membrane dynamics. Multiple transcript variants encoding different isoforms have been found for this gene. |
|||
Anti-Anti-MARCH6 Antibody antibody |
|||
STJ118549 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-MARCH6 Antibody antibody |
|||
STJ118550 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-MARCH7 Antibody antibody |
|||
STJ118752 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT3 Antibody antibody |
|||
STJ118990 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT11 Antibody antibody |
|||
STJ113941 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT11 Antibody antibody |
|||
STJ114081 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT5 Antibody antibody |
|||
STJ114819 | St John's Laboratory | 100 µl | 332.4 EUR |
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
|||
Anti-Anti-MARCH8 Antibody antibody |
|||
STJ114828 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT7 Antibody antibody |
|||
STJ116214 | St John's Laboratory | 100 µl | 332.4 EUR |
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
|||
Anti-Anti-SEPT8 Antibody antibody |
|||
STJ117206 | St John's Laboratory | 100 µl | 332.4 EUR |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
|||
CLCN5 Antibody / CIC-5 antibody |
|||
RQ6462 | NSJ Bioreagents | 100ug | 419 EUR |
Description: The CLCN5 gene encodes the chloride channel Cl-/H+ exchanger ClC-5. This gene encodes a member of the ClC family of chloride ion channels and ion transporters. The encoded protein is primarily localized to endosomal membranes and may function to facilitate albumin uptake by the renal proximal tubule. Mutations in this gene have been found in Dent disease and renal tubular disorders complicated by nephrolithiasis. Alternatively spliced transcript variants have been found for this gene. |
|||
Cytokeratin 7 antibody-Cytoskeleton Marker Antibody |
|||
48169-100ul | SAB | 100ul | 399.6 EUR |
Cytokeratin 7 antibody-Cytoskeleton Marker Antibody |
|||
48169-50ul | SAB | 50ul | 286.8 EUR |
Antibody Pair to ApoA-V antibody |
|||
10R-1876 | Fitzgerald | 100 ul | 781.2 EUR |
Description: Mouse monoclonal Antibody Pair to ApoA-V antibody |
|||
Anti CD22 Antibody: CD22 Monoclonal Antibody |
|||
065-A-01mg | Virogen | 0,1 mg | 321 EUR |
Description: anti-CD22 monoclonal antibody |
|||
Anti CD22 Antibody: CD22 Monoclonal Antibody |
|||
065-A-1000ug | Virogen | 1000 ug | 1539 EUR |
Description: anti-CD22 monoclonal antibody |
|||
Ly1 Antibody Reactive Homolog (LYAR) Antibody |
|||
20-abx103034 | Abbexa |
|
|
Ly1 Antibody Reactive Homolog (LYAR) Antibody |
|||
20-abx103035 | Abbexa |
|
|
Ly1 Antibody Reactive Homolog (LYAR) Antibody |
|||
20-abx103036 | Abbexa |
|
|
Hepatitis C Virus Antibody (HCV) Antibody |
|||
abx023924-1mg | Abbexa | 1 mg | 1446 EUR |
Anti-Glycoprotein 210 Antibody (gp210) Antibody |
|||
abx233571-100ug | Abbexa | 100 ug | 577.2 EUR |
Anti Deoxyribonucleic Acid Antibody (DNA) Antibody |
|||
abx411057-50ug | Abbexa | 50 ug | 710.4 EUR |
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
|||
20-abx319902 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
|||
20-abx319903 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
|||
20-abx319904 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
|||
20-abx319906 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
|||
20-abx319907 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
|||
20-abx319908 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
|||
20-abx319914 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
|||
20-abx319915 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
|||
20-abx319916 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
|||
20-abx319929 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
|||
20-abx319930 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
|||
20-abx319931 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody (HRP) |
|||
20-abx311666 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody (FITC) |
|||
20-abx311667 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody (Biotin) |
|||
20-abx311668 | Abbexa |
|
|
Monoclonal NGF/proNGF Neutralizing Antibody Antibody |
|||
AMM06679G | Leading Biology | 0.05mg | 633.6 EUR |
Description: A Monoclonal antibody against Human NGF/proNGF Neutralizing. The antibodies are raised in Mouse. This antibody is applicable in E |
|||
Goat anti- human Antibody^Polyclonal antibody |
|||
LSMab09896 | Lifescience Market | 100 ug | 525.6 EUR |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D | Stressmarq | 0.1mg | 424.8 EUR |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is unconjugated. |
|||
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-A390 | Stressmarq | 0.1mg | 481.2 EUR |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 390. |
|||
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-A488 | Stressmarq | 0.1mg | 480 EUR |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 488. |
|||
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-A565 | Stressmarq | 0.1mg | 480 EUR |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 565. |
|||
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-A594 | Stressmarq | 0.1mg | 480 EUR |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 594. |
|||
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-A633 | Stressmarq | 0.1mg | 480 EUR |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 633. |
|||
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-A655 | Stressmarq | 0.1mg | 480 EUR |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 655. |
|||
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-A680 | Stressmarq | 0.1mg | 480 EUR |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 680. |
|||
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-A700 | Stressmarq | 0.1mg | 480 EUR |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 700. |
|||
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-ALP | Stressmarq | 0.1mg | 472.8 EUR |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Alkaline Phosphatase. |
|||
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-APC | Stressmarq | 0.1mg | 478.8 EUR |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to APC . |
The authors mixed demographic and genetic knowledge to indicate that, at websites with heavier predation, the remaining females had been extra more likely to mate with a number of males. This shift in the mating system additionally led to decrease general nesting success, with fewer chicks fledged per nest at websites with increased ranges of blended paternity.